Showing results (2081-2090 of 2,130) with videos related to

Sort By:
Pageof 213
BMC Emergency Medicine|March 5, 2025
Understanding oncologic emergencies and related emergency department visits and hospitalizations: a systematic reviewSule Yilmaz, Komal Aryal, Jasmine King, et al.
Critical Care (London, England)|September 13, 2022
Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational studyLuis Felipe Reyes, Srinivas Murthy, Esteban Garcia-Gallo, et al.
Acta Neuropathologica|January 4, 2024
Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer's diseaseAna Rita Agra Almeida Quadros, Zhaozhi Li, Xue Wang, et al.
Transplantation|October 1, 2025
Characterization of Spirometric Response to Standard-of-care Treatment in Lung Allograft Recipients With Bronchiolitis Obliterans and the Utility of Spirometric Criteria for Rescue Therapy: Implications for the Design of Risk-stratified Clinical TrialsDerek E Byers, Ramsey Hachem, Chadi A Hage, et al.
Implementation Science : IS|February 25, 2025
Evidence based QUality Improvement for Prescribing Stewardship in ICU (EQUIPS-ICU): protocol for type III hybrid implementation-effectiveness studyDuncan Wagstaff, John Amuasi, Sumaiya Arfin, et al.
BMJ Global Health|May 30, 2019
Designing and implementing an integrated non-communicable disease primary care intervention in rural NepalAnirudh Kumar, Dan Schwarz, Bibhav Acharya, et al.
Journal of the American College of Cardiology|August 18, 2022
The Association of Socioeconomic Status With Hypertension in 76 Low- and Middle-Income CountriesTabea K Kirschbaum, Nikkil Sudharsanan, Jennifer Manne-Goehler, et al.
Transplantation Direct|September 24, 2025
Identification of Surrogate Outcome Biomarkers in Lung Allograft Recipients With Bronchiolitis Obliterans: Implications for Randomized Controlled TrialsDerek E Byers, Ramsey Hachem, Chadi A Hage, et al.
Molecular Cancer Therapeutics|April 15, 2026
Targeting the chromatin modifying enzyme, KDM5C, enhances AKT inhibition response in ER+ breast cancerValentina Cutano, Shanade Dunn, Sungmi Park-Chouinard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 2021
Fostamatinib for the Treatment of Hospitalized Adults With Coronavirus Disease 2019: A Randomized TrialJeffrey R Strich, Xin Tian, Mohamed Samour, et al.
Pageof 213